Neutrogena

Senior Business Leader Joins SMU Cox Spears Institute for Entrepreneurial Leadership

Retrieved on: 
Monday, March 11, 2024
Entrepreneurial leadership, Television, Fortune 500, SMU, Shopping.com, Entrepreneurship, Culture, Growth, MBA, Spear, Stanford University, Lead, University, Faculty, History, Nirav, Epinions, Benchmark (venture capital firm), Executive, Acceleration, Harvard Business School, Neutrogena, Internet, Megha, Student, Management

Dallas, TX (SMU), March 11, 2024 (GLOBE NEWSWIRE) -- Veteran leader Joshua Taylor has joined SMU Cox School of Business as the Managing Director of the William S. Spears Institute for Entrepreneurial Leadership .

Key Points: 
  • Dallas, TX (SMU), March 11, 2024 (GLOBE NEWSWIRE) -- Veteran leader Joshua Taylor has joined SMU Cox School of Business as the Managing Director of the William S. Spears Institute for Entrepreneurial Leadership .
  • Taylor brings 20 years of experience in senior leadership roles in strategy consulting, Fortune 500 and start-up organizations.
  • Dr. Spears, Founder and Chairman of Cenergistic, launched the Institute in April 2022 with the largest gift by a non-alumnus in the history of SMU.
  • The gift creating the Spears Institute for Entrepreneurial Leadership was a signature moment for SMU Ignited: Boldly Shaping Tomorrow, the University’s $1.5 billion campaign for impact.

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Retrieved on: 
Monday, February 26, 2024
TSX, Toronto Stock Exchange, Exercise, Transaction, Aeterna, Avenanthramide, Text, Pharmacy, Proxy, Neutrogena, Aveeno, Research, Management

These revenue streams will be used to support the development of high potential-return products and represent a more diversified value proposition for investors.

Key Points: 
  • These revenue streams will be used to support the development of high potential-return products and represent a more diversified value proposition for investors.
  • The issuance of Aeterna Zentaris Shares, Transaction Warrants and Replacement Options by Aeterna Zentaris under the Transaction is subject to the approval of a simple majority of the votes cast by Aeterna shareholders at a special meeting of Aeterna Zentaris shareholders.
  • ISS recommended that Aeterna Zentaris shareholders vote FOR all of these resolutions as part of the Transaction.
  • Aeterna Zentaris and Ceapro securityholders must vote their proxy before 11:00 a.m. (Eastern time) on March 8, 2024.

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

Retrieved on: 
Monday, February 26, 2024
TSX, Toronto Stock Exchange, Exercise, Transaction, Aeterna, Avenanthramide, Text, Pharmacy, Proxy, Neutrogena, Aveeno, Research, Management

These revenue streams will be used to support the development of high potential-return products and represent a more diversified value proposition for investors.

Key Points: 
  • These revenue streams will be used to support the development of high potential-return products and represent a more diversified value proposition for investors.
  • The issuance of Aeterna Zentaris Shares, Transaction Warrants and Replacement Options by Aeterna Zentaris under the Transaction is subject to the approval of a simple majority of the votes cast by Aeterna shareholders at a special meeting of Aeterna Zentaris shareholders.
  • ISS recommended that Aeterna Zentaris shareholders vote FOR all of these resolutions as part of the Transaction.
  • Aeterna Zentaris and Ceapro securityholders must vote their proxy before 11:00 a.m. (Eastern time) on March 8, 2024.

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

Retrieved on: 
Thursday, February 15, 2024
Letter, Shareholder, TSX, Toronto Stock Exchange, Growth, Risk, Proxy, Pharmacy, Knowledge, Neutrogena, Aveeno, FGS

The two innovative biopharmaceutical development companies previously announced that they had entered into a definitive agreement to combine operations in an all-stock merger of equals transaction (the "Transaction").

Key Points: 
  • The two innovative biopharmaceutical development companies previously announced that they had entered into a definitive agreement to combine operations in an all-stock merger of equals transaction (the "Transaction").
  • A new name for the combined company is expected to be announced following the closing of the Transaction.
  • Ceapro currently generates revenues from two main active ingredients, oat beta glucan and avenanthramides, extracted and purified using its proprietary technology.
  • Both companies have expertise that can build upon each other, which is expected to result in a stronger combined company.

Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

Retrieved on: 
Thursday, February 15, 2024
Court, Issuer, Shareholder, Arrangement, Post office box, Meeting, TSX, Toronto Stock Exchange, News, Aeterna, Avenanthramide, Proxy, Pharmacy, Knowledge, Neutrogena, Aveeno, Internet, Security (finance)

The Board believes this is a compelling opportunity for Ceapro and its investors for a number of reasons, including:

Key Points: 
  • The Board believes this is a compelling opportunity for Ceapro and its investors for a number of reasons, including:
    Recurring revenue to support business expansion.
  • The pipeline of products being developed should generate an increased and consistent news flow, a key supporting factor in investor interest.
  • Only Securityholders of record as of the close of business on January 12, 2024 are eligible to vote at the Meeting.
  • Registered Securityholders and duly appointed proxyholders may vote on matters presented at the Meeting by:
    Virtually – completing a ballot online during the Meeting.

Minu Reimagines What's Possible in Mineral Sunscreen

Retrieved on: 
Thursday, February 1, 2024
Cream, Mineral, Peptide, Vitamin, Magic, SPF, Nudity, Skin, Entrepreneurship, Beauty, Neutrogena, UVB, Cosmetics

LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- Minu - Minerals in the Nude - is dermatologist-designed mineral skincare for all, with daily sun protection at its core. Minu announced today its debut nationwide at Credo Beauty and directly on their website with the launch of its first prestige skincare product, Brightening Sunscreen Minerals Broad Spectrum SPF 30 Gel-Cream.

Key Points: 
  • LOS ANGELES, Feb. 1, 2024 /PRNewswire/ -- Minu - Minerals in the Nude - is dermatologist-designed mineral skincare for all, with daily sun protection at its core.
  • Minu announced today its debut nationwide at Credo Beauty and directly on their website with the launch of its first prestige skincare product, Brightening Sunscreen Minerals Broad Spectrum SPF 30 Gel-Cream .
  • With its proprietary Mineral Superblend™ technology, a delicate fusion of the finest minerals with plant extracts, vitamins, and peptides, Minu has created your skin's new essential: a daily facial mineral sunscreen, moisturizer and primer in one, without compromise.
  • "Like Credo, Minu is pushing industry standards forward, proving that clean beauty can also deliver better beauty in all aspects."

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

Retrieved on: 
Thursday, December 14, 2023
Par value, Aveeno, EDGAR, Research, Pharmacy, LLP, Consolidation, Transaction, TMX Group, Neutrogena, FGS, Arrangement, Growth, TSX, Toronto Stock Exchange, Exercise, Blake, Cassels & Graydon, Security (finance)

Shareholders of each company will share in future value creation, with existing securityholders of Aeterna and Ceapro to each own 50% of the combined company, respectively (assuming the exercise of all Transaction Warrants (as defined below)).

Key Points: 
  • Shareholders of each company will share in future value creation, with existing securityholders of Aeterna and Ceapro to each own 50% of the combined company, respectively (assuming the exercise of all Transaction Warrants (as defined below)).
  • The anticipated dual Nasdaq and TSX listing is expected to provide additional volume and an improved capital market profile for the combined company.
  • The terms of the Transaction are set out in a definitive arrangement agreement (the “Arrangement Agreement”) between Aeterna and Ceapro.
  • Similarly, certain officers and directors of Aeterna have entered into lock-up agreements with Ceapro, agreeing to vote their Aeterna common shares in favour of the Transaction.

Bundle up to spend flexible spending account (FSA) dollars before the December 31 use-it-or-lose-it deadline with 10 exclusive product bundles from FSA Store

Retrieved on: 
Tuesday, December 26, 2023
Sinusitis, Allergy, Pain, Health, Commerce, Neutrogena, Pedialyte, Motion, Tylenol, Aura, Calendar, Acne, FSA, Myalgia, Massage, Travel, Ship, Pressure, Medicine cabinet, Skin, Life

DALLAS, Dec. 26, 2023 /PRNewswire-PRWeb/ -- Giving gifts to loved ones is a highlight of the holiday season, but the end of the year is also an opportunity for shoppers to give themselves the gift of better health while protecting their tax-free healthcare funds. For the millions of flexible spending account (FSA) users who face a December 31 use-it-or-use it deadline, this is the time to manage last-minute spending and avoid forfeiting an average of $300 to a missed deadline. FSA Store® makes it easy and efficient to spend FSA funds by offering exclusive product bundles that allow consumers to find and buy related products that are grouped according to popular themes or needs.

Key Points: 
  • For the millions of flexible spending account (FSA) users who face a December 31 use-it-or-use it deadline, this is the time to manage last-minute spending and avoid forfeiting an average of $300 to a missed deadline.
  • FSA Store ® makes it easy and efficient to spend FSA funds by offering exclusive product bundles that allow consumers to find and buy related products that are grouped according to popular themes or needs.
  • Our exclusive product bundles are the perfect way to spend funds – whether you have $20 or $200 in your FSA – on items that you will use every day.
  • To learn more about the FSA deadline and how to spend funds before Dec. 31, visit FSAstore.com and the FSA Learning Center .

Skincare Awareness and Moisturizer Demand Propel Dry Skin Care Market to US$ 86.1 Billion by 2034 | Future Market Insights, Inc.

Retrieved on: 
Wednesday, December 6, 2023
Well, Associate, Hotaru, Price analysis, Research, Johnson & Johnson, Business, Beauty, Irritation, PDF, Competitive landscape, The Estée Lauder Companies, Skin care, L'Oréal, E-commerce, Growth, Skin, Inflammation, Petroleum jelly, Cosmetics, Retail, Unilever, Neutrogena

NEWARK, Del., Dec. 6, 2023 /PRNewswire/ -- The global dry skin cream, lotion, and ointment market is estimated to be US$ 40.4 billion in 2024. The market is projected to exhibit a CAGR of 8.6% over the forecast period and reach US$ 86.1 billion by 2034.

Key Points: 
  • The global dry skin care products market is poised for significant growth in the coming years, propelled by increasing awareness of dry skin conditions and escalating disposable income levels.
  • NEWARK, Del., Dec. 6, 2023 /PRNewswire/ -- The global dry skin cream, lotion, and ointment market is estimated to be US$ 40.4 billion in 2024.
  • Dry skin creams and lotions are also becoming important in daily skin care routines due to their easy availability and affordability.
  • The dry skin cream, lotion, and ointment market in Japan has the potential to increase at 7.80% CAGR through 2034.

Skincare Awareness and Moisturizer Demand Propel Dry Skin Care Market to US$ 86.1 Billion by 2034 | Future Market Insights, Inc.

Retrieved on: 
Wednesday, December 6, 2023
Well, Associate, Hotaru, Price analysis, Research, Johnson & Johnson, Business, Beauty, Irritation, PDF, Competitive landscape, The Estée Lauder Companies, Skin care, L'Oréal, E-commerce, Growth, Skin, Inflammation, Petroleum jelly, Cosmetics, Retail, Unilever, Neutrogena

NEWARK, Del., Dec. 6, 2023 /PRNewswire/ -- The global dry skin cream, lotion, and ointment market is estimated to be US$ 40.4 billion in 2024. The market is projected to exhibit a CAGR of 8.6% over the forecast period and reach US$ 86.1 billion by 2034.

Key Points: 
  • The global dry skin care products market is poised for significant growth in the coming years, propelled by increasing awareness of dry skin conditions and escalating disposable income levels.
  • NEWARK, Del., Dec. 6, 2023 /PRNewswire/ -- The global dry skin cream, lotion, and ointment market is estimated to be US$ 40.4 billion in 2024.
  • The dry skin cream, lotion, and ointment market in Japan has the potential to increase at 7.80% CAGR through 2034.
  • The dry skin cream, lotion, and ointment market in France is predicted to grow at a CAGR of 6.60% through 2034.